Cardiac arrest & resuscitation

Evaluation of Use of Epinephrine and Time to First Dose and Outcomes in Pediatric Patients With Out-of-Hospital Cardiac Arrest

JAMA Netw OpenPublished Cohort study

Main finding · Survival to hospital dischargeResult — go to the resultRR for survival to hospital discharge 2.09 95% CI 1.29–3.40

Authors' conclusion

In this study of pediatric patients with OHCA in the US and Canada, epinephrine administration was associated with survival to hospital discharge, while timing of the administration was not associated with survival.

Study context

Population
Pediatric patients (<18 years) with out-of-hospital cardiac arrest (OHCA) treated by emergency medical services (EMS), Resuscitation Outcomes Consortium Epidemiologic Registry, 10 sites in the US and Canada, April 2011 to June 2015propensity-matched cohort
Participants
1,432 patients
Exposure
Prehospital IV or intraosseous epinephrine vs no epinephrine
  • Epinephrinen = 716
  • At-riskn = 716reference
Outcome
Survival to hospital discharge
Methodological detailstime-dependent propensity-score matched, prospective multicentre registry
  • Time-dependent propensity-score matched
  • Prospective multicentre registry

Main finding

As reported in the abstract

RR for survival to hospital discharge

2.09

95% CI 1.29–3.40

Events by group

Epinephrine vs At-risk
RR for survival to hospital discharge 2.09 (95% CI 1.29–3.40)

Observational data: associations, not effects.

Further findings

Time from advanced life support (ALS) arrival to epinephrine
9 · median · IQR 6.2–12.1 · minutes

Timing of epinephrine and survival to hospital discharge

Timing of epinephrine not associated with survival to hospital discharge
  • P for interaction = .34

Original publication

Evaluation of Use of Epinephrine and Time to First Dose and Outcomes in Pediatric Patients With Out-of-Hospital Cardiac Arrest. JAMA Netw Open. Published 1 March 2023. doi:10.1001/jamanetworkopen.2023.5187

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.